Virtual ADC & Bioconjugation Symposium – December 2-3, 2020

ADC & Bioconjugation Symposium | 100% Digital

We cordially invite you to participate in our 2020 Technical Symposium to discover enabling technologies and the latest trends in drug development and processing. During this virtual event, industry experts will be presenting the latest progress in ADC and Bioconjugation.

• Learn about advancements in drug development, drug-linker technologies and product characterization.
• Get perspectives on successful strategies for your ADC and bioconjugation programs.
• Tackle today’s challenges and discuss solutions with your peers.

Choose your date and register today!

Wednesday Dec 2, 5:00 – 7:30 PM Central European Time

Chair: Dr. Eric Lacoste, Sanofi

Presentations:

• Clinical-Stage GlycoConnect™ Technology as a Powerful Platform to Generate ADCs and Bispecific Antibodies, Dr. R. van Geel, Synaffix
• Taming random conjugation: producing monodisperse ADCs from native antibodies, Dr. S. Kolodych, Syndivia
• The Benefits of Using Orthogonal Analytics in ADC Drug Development, Dr. D. Galbraith, Merck KGaA, Darmstadt, Germany
• Commercializing antibody-drug conjugates: a CMO’s journey, Elizabeth Mc Kee and Jeff Carroll
• Payloads to Accelerate the ADC Clinical Path, Dr. D. Goddel, Merck KGaA, Darmstadt, Germany

 Thursday Dec 3, 6:30 – 9:00 AM Central European Time

Chair: Dr. Matthias Joehnck, Merck KGaA, Darmstadt, Germany

Presentations:

• MORAb-202, a Folate Receptor Alpha-targeted Antibody-drug Conjugate, loaded with HALAVEN® (eribulin) as payload, Dr. T. Uenaka, Eisai Inc.
• Payloads to Accelerate the ADC Clinical Path, Dr. D. Goddel, Merck KGaA, Darmstadt, Germany
• Engineered Avibodies^TM (improved Diabodies) precisely loaded with novel ADC payloads that surpass IgG-ADCs in cancer therapy, Dr. P. Hudson, Avipep
• ABL202/LCB71: a ROR1-targeting antibody-drug conjugate for treating TNBC and CLL, Dr. J. Jung, ABL Bio
• The Benefits of Using Orthogonal Analytics in ADC Drug Development, Dr. D. Galbraith, Merck KGaA, Darmstadt, Germany

Abstracts and details of the webcast can be found on the registration page. The agenda is subject to change.